Dry Eye Relief

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation associated with dryness of the eye. It is also indicated for the temporary relief of discomfort resulting from minor irritations of the eye or exposure to environmental factors such as wind and sun.

Additionally, this drug serves as a protectant against further irritation and is utilized to relieve dryness of the eye. It functions as a lubricant to prevent additional irritation and to alleviate symptoms of dryness.

Dosage and Administration

Healthcare professionals should instruct patients to wash their hands thoroughly before using the medication.

To administer the drops, the patient should first remove the tamper-evident ring and then take off the cap. The bottle should be tilted downward or upside down while gently squeezing to instill 1 or 2 drops into the affected eye(s) as needed.

After administration, it is important to tilt the bottle downward and shake it lightly to remove any residual drops that may remain on the tip. Finally, the cap should be securely replaced after use to maintain the integrity of the product.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to any of its ingredients.

Additionally, the product should not be used if the solution has changed color or become cloudy, if the tamper-evident seal is broken or missing, or if the bottle is damaged. These conditions may indicate compromised product integrity or safety.

Warnings and Precautions

For external use only. To prevent contamination, it is imperative that the tip of the container not be touched to any surface. Healthcare professionals should be aware that in rare instances, hypersensitivity reactions may occur, presenting as redness, burning, swelling, or itching.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be advised to discontinue use and consult a physician if they experience any of the following: eye pain, changes in vision, or persistent redness or irritation of the eye. Additionally, if the condition worsens or does not improve within 72 hours, medical advice should be sought.

Side Effects

In rare cases, patients may experience hypersensitivity reactions, which can manifest as redness, burning, swelling, and itching. It is important to note that the product should not be used by individuals who are allergic to any of its ingredients.

Patients are advised to seek medical attention if they experience eye pain, changes in vision, or if there is continued redness or irritation of the eye. Additionally, if the condition worsens or persists for more than 72 hours, it is recommended to consult a healthcare professional.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dry Eye Relief (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that no specific information regarding the use of this product during pregnancy is provided in the prescribing information. There are no statements indicating whether the product is contraindicated in pregnancy or any associated risks to the fetus. Additionally, there are no dosage modifications or special precautions regarding the use of this product during pregnancy. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The effects on the nursing infant are not well studied; thus, the risks versus benefits should be considered.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

In rare cases, hypersensitivity reactions have been reported, including symptoms such as redness, burning, swelling, and itching. These events were identified through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the medication if the solution changes color or becomes cloudy, if the tamper-evident seal is broken or missing, if the bottle is damaged, or if they are allergic to any of the ingredients.

Additionally, healthcare providers should counsel patients to stop using the medication and consult a doctor if they experience any eye pain, changes in vision, or if there is continued redness or irritation of the eye. Patients should also be advised to seek medical attention if their condition worsens or persists for more than 72 hours.

Storage and Handling

The product is supplied in packaging that includes an expiration date located on the bottom of the box. It is essential to adhere to this expiration date and not use the product for more than 30 days after opening.

For optimal storage, the product should be maintained at a temperature range of 59-77°F. Proper handling and storage conditions are crucial to ensure the integrity and efficacy of the product throughout its use.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Dry Eye Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)